HAVCR2 and acute myeloid leukemia: Second, we evaluated the expression of TIM-3 and its ligands in human primary AML cells isolated from patients that experienced a relapse after allo-HCT at multiple transplant centers (Supplemental Table 2) using bulk RNA-Seq.